B. Géry

1.6k total citations
23 papers, 471 citations indexed

About

B. Géry is a scholar working on Otorhinolaryngology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, B. Géry has authored 23 papers receiving a total of 471 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Otorhinolaryngology, 14 papers in Surgery and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in B. Géry's work include Head and Neck Cancer Studies (19 papers), Head and Neck Surgical Oncology (10 papers) and Oral health in cancer treatment (5 papers). B. Géry is often cited by papers focused on Head and Neck Cancer Studies (19 papers), Head and Neck Surgical Oncology (10 papers) and Oral health in cancer treatment (5 papers). B. Géry collaborates with scholars based in France, Switzerland and Belgium. B. Géry's co-authors include Jean Bourhis, D. De Raucourt, François Janot, Christophe Ferron, É. Bardet, René‐Jean Bensadoun, Gilles Dolivet, Marine Castaing, M. Juliéron and Vincent Grégoire and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Radiotherapy and Oncology.

In The Last Decade

B. Géry

23 papers receiving 466 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. Géry France 9 367 287 164 156 74 23 471
Ljiljana Tadić Serbia 6 418 1.1× 302 1.1× 222 1.4× 172 1.1× 44 0.6× 13 495
Luciana Lastrucci Italy 9 250 0.7× 131 0.5× 179 1.1× 111 0.7× 36 0.5× 12 344
Sai Ki O China 7 319 0.9× 243 0.8× 191 1.2× 151 1.0× 48 0.6× 8 441
Fernando Freire de Arruda Brazil 6 477 1.3× 264 0.9× 327 2.0× 136 0.9× 178 2.4× 11 614
Esengul Kocak–Uzel United States 10 262 0.7× 160 0.6× 237 1.4× 102 0.7× 137 1.9× 13 460
L. Portugal United States 5 431 1.2× 313 1.1× 180 1.1× 159 1.0× 32 0.4× 13 551
Sandro Tonoli Italy 8 215 0.6× 148 0.5× 232 1.4× 102 0.7× 26 0.4× 22 394
Catherine Coyle United Kingdom 10 187 0.5× 240 0.8× 156 1.0× 161 1.0× 28 0.4× 21 466
Gopal Bajaj United States 11 157 0.4× 129 0.4× 127 0.8× 88 0.6× 28 0.4× 21 286
J.A. Marks United States 3 399 1.1× 228 0.8× 208 1.3× 149 1.0× 67 0.9× 5 576

Countries citing papers authored by B. Géry

Since Specialization
Citations

This map shows the geographic impact of B. Géry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Géry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Géry more than expected).

Fields of papers citing papers by B. Géry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Géry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Géry. The network helps show where B. Géry may publish in the future.

Co-authorship network of co-authors of B. Géry

This figure shows the co-authorship network connecting the top 25 collaborators of B. Géry. A scholar is included among the top collaborators of B. Géry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Géry. B. Géry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Perrier, Lionel, Frédéric Balusson, J. Castelli, et al.. (2024). Cost-effectiveness of weekly adaptive radiotherapy versus standard IMRT in head and neck cancer alongside the ARTIX trial. Radiotherapy and Oncology. 193. 110116–110116. 4 indexed citations
2.
Géry, B., et al.. (2023). Effect of lymphoid volume irradiation on radiation-induced lymphopenia in head and neck cancers. Cancer/Radiothérapie. 27(2). 145–153. 2 indexed citations
3.
Castelli, J., Juliette Thariat, Karen Bénézery, et al.. (2023). Weekly Adaptive Radiotherapy vs Standard Intensity-Modulated Radiotherapy for Improving Salivary Function in Patients With Head and Neck Cancer. JAMA Oncology. 9(8). 1056–1056. 31 indexed citations
4.
Heutte, Natacha, Bénédicte Clarisse, Alexandra Leconte, et al.. (2023). Head and neck cancer patients under radiotherapy undergoing skin application of hydrogel dressing or hyaluronic acid: results from a prospective, randomized study. Supportive Care in Cancer. 32(1). 7–7. 3 indexed citations
5.
Guévelou, Jennifer Le, Vianney Bastit, Pierre Yves Marcy, et al.. (2020). Flap delineation guidelines in postoperative head and neck radiation therapy for head and neck cancers. Radiotherapy and Oncology. 151. 256–265. 13 indexed citations
6.
Géry, B., et al.. (2020). Routine feasibility of postoperative chemoradiotherapy in head and neck squamous cell carcinoma at high risk of recurrence. European Annals of Otorhinolaryngology Head and Neck Diseases. 137(5). 371–375. 1 indexed citations
7.
Thariat, Juliette, B. Géry, Vianney Bastit, et al.. (2020). Dix ans de progrès en chirurgie des tumeurs de la tête et du cou, quel impact sur la radiothérapie postopératoire ?. Bulletin du Cancer. 107(7-8). 823–829. 3 indexed citations
9.
Johnson, Alison, et al.. (2019). Traitements systémiques du carcinome adénoïde kystique de la sphère ORL localement avancé ou métastatique, une revue systématique. Bulletin du Cancer. 106(10). 923–938. 6 indexed citations
10.
Licaj, Idlir, B. Géry, R. Gervais, et al.. (2019). Platinum rechallenge in recurrent head and neck squamous cell carcinoma after primary chemoradiation. European Annals of Otorhinolaryngology Head and Neck Diseases. 136(4). 257–261. 6 indexed citations
11.
Bastit, Vianney, S. Thureau, Juliette Thariat, et al.. (2019). Impact of locoregional irradiation in patients with upfront metastatic head and neck squamous cell carcinoma. Oral Oncology. 93. 46–51. 10 indexed citations
13.
Kinj, Rémy, et al.. (2018). Réirradiation des tumeurs de la tête et du cou : volumes cibles, évolutions techniques et perspectives. Cancer/Radiothérapie. 22(2). 171–179. 1 indexed citations
14.
Sun, Xu, Cécile Michel, E. Babin, et al.. (2018). Approach to Oligometastatic Disease in Head and Neck Cancer, on Behalf of the GORTEC. Future Oncology. 14(9). 877–889. 25 indexed citations
15.
Gervais, Radj, D. De Raucourt, E. Babin, et al.. (2017). Retrospective evaluation of concomitant cetuximab and radiotherapy tolerance for locoregional advanced head and neck squamous cell carcinoma treatment in patients unfit for platinum-based chemotherapy. European Archives of Oto-Rhino-Laryngology. 274(7). 2883–2889. 6 indexed citations
16.
Tao, Yungan, Anne Aupérin, P. Gräff, et al.. (2017). Very accelerated radiotherapy or concurrent chemoradiotherapy for N3 head and neck squamous cell carcinoma: Pooled analysis of two GORTEC randomized trials. Oral Oncology. 71. 61–66. 10 indexed citations
17.
Blanchard, D., et al.. (2016). Intensive nutritional care for patients treated with radiotherapy in head and neck cancer: a randomized study and meta-analysis. European Archives of Oto-Rhino-Laryngology. 274(2). 977–987. 20 indexed citations
18.
Blanchard, D., et al.. (2014). Cancer de l’oropharynx. Bulletin du Cancer. 101(5). 429–437. 5 indexed citations
19.
Géry, B., Bénédicte Clarisse, D. Blanchard, et al.. (2013). Exclusive radiotherapy for stage T1-T2N0M0 lanryngeal cancer: Retrospective study of 59 patients at CFB and CHU de Caen. European Annals of Otorhinolaryngology Head and Neck Diseases. 130(5). 251–256. 2 indexed citations
20.
Janot, François, D. De Raucourt, E Benhamou, et al.. (2008). Randomized Trial of Postoperative Reirradiation Combined With Chemotherapy After Salvage Surgery Compared With Salvage Surgery Alone in Head and Neck Carcinoma. Journal of Clinical Oncology. 26(34). 5518–5523. 282 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026